Literature DB >> 16695296

HEMORRHAGIC SHOCK: DEFINITION AND CRITERIA FOR ITS DIAGNOSIS.

H C Wiggers1, R C Ingraham.   

Abstract

Year:  1946        PMID: 16695296      PMCID: PMC435535          DOI: 10.1172/JCI101686

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  1 in total

1.  TRAUMATIC SHOCK: IV. A STUDY OF THE PROBLEM OF THE "LOST PLASMA" IN HEMORRHAGIC SHOCK BY THE USE OF RADIOACTIVE PLASMA PROTEIN.

Authors:  J Fine; A M Seligman
Journal:  J Clin Invest       Date:  1943-03       Impact factor: 14.808

  1 in total
  7 in total

1.  Splanchnic organ adenine nucleotides and their netabolites in haemorrhagic shock.

Authors:  S K Cunningham; T V Keaveny
Journal:  Ir J Med Sci       Date:  1977-05       Impact factor: 1.568

2.  Empiric antimicrobial therapy in severe sepsis and septic shock: optimizing pathogen clearance.

Authors:  Stephen Y Liang; Anand Kumar
Journal:  Curr Infect Dis Rep       Date:  2015-07       Impact factor: 3.725

3.  Hemorrhagic shock: the effect of prolonged low flow on the regional distribution of blood and its modification by hypothermia.

Authors:  D Race; E Cooper; M Rosenbaum
Journal:  Ann Surg       Date:  1968-04       Impact factor: 12.969

4.  Old unhappy far off things. Some reflections on the significance of the early work on shock.

Authors:  A R Hunter
Journal:  Ann R Coll Surg Engl       Date:  1967-05       Impact factor: 1.891

5.  The role of replacement fluids in the management of haemorrhagic shock: an experimental study.

Authors:  R Rajagopalan; G C Tandan; G R Gode
Journal:  Can Anaesth Soc J       Date:  1969-05

Review 6.  Heart failure in experimental refractory shock.

Authors:  I M Ledingham
Journal:  Eur J Intensive Care Med       Date:  1976-11

7.  The role of pre-hospital blood gas analysis in trauma resuscitation.

Authors:  Milla Jousi; Janne Reitala; Vesa Lund; Ari Katila; Ari Leppäniemi
Journal:  World J Emerg Surg       Date:  2010-04-22       Impact factor: 5.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.